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Aim: Transplant chorioretinopathy is a rare complication following solid organ or bone   marrow 
transplantation and can result in severe vision loss. This series presents electroretinogram (ERG) 
results in patients with this condition.
Methods: Patients who presented with bilateral vision loss following bone marrow or solid organ 
transplantation were identified. A complete ophthalmologic examination, fundus   photography, 
and fluorescein angiography (FA) were performed. Full-field ERG was obtained in all patients 
and a multifocal ERG (mfERG) was obtained in two patients.
Results: Four patients were identified. All patients had bilateral vision loss and displayed a 
characteristic pattern of mottled hyperfluorescence on FA. Three patients developed   progressive 
vision loss ranging from 20/60 to hand motions whereas one retained 20/40 vision. All patients 
exhibited moderate to severe cone dysfunction, while the degree of rod abnormalities was 
varied. Two patients with severe cone dysfunction showed mild clinical changes initially, but 
later developed progressive vision loss and chorioretinal atrophy.
Conclusion: Transplant chorioretinopathy patients undergoing ERG testing show cone 
  dysfunction with a variable degree of rod dysfunction. ERG abnormalities preceded the visual 
acuity and clinical changes in two patients, suggesting that ERG may be a helpful predictor of 
the clinical course in this rare disease.
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Introduction
Ophthalmic complications associated with bone marrow or solid organ transplantation 
include a number of anterior segment and posterior segment findings. Transplant-related 
chorioretinopathy features vasculopathy of the choroid and retina, retinal pigment 
  epithelial (RPE) atrophy, and serous retinal detachment, all of which may result in visual 
loss.1–9 Although other authors have corroborated initial observations of this condition, an 
understanding of the precise mechanisms underlying this condition is incomplete. In some 
instances, complaints of decreased vision may precede ophthalmoscopic findings.
Retinal electrophysiologic testing is a useful technique detecting and categorizing 
retinal dysfunction, and is particularly helpful in patients who do not display discernible 
pathologic changes using ophthalmoscopy, or other vascular or structural modalities 
of retina imaging.
To characterize this rare and potentially visually debilitating entity further, 
we describe a series of four patients with transplant-associated chorioretinopathy, 
  representative ERG features, and their long-term follow-up.Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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Methods
Prior to performing a retrospective case review of the 
affected patients, approval from the Oregon Health and 
Science   University institutional review board was obtained 
in   compliance with the Health Insurance   Portability 
and   Accountability Act of 1996. The records of four patients 
with transplant chorioretinopathy were reviewed. All patients 
had previously undergone complete   ophthalmologic exami-
nation, fundus photography, and fluorescein angiography.
A full-field electroretinogram (ERG) was performed 
using protocols that are consistent with the guide-
lines set out by the International Society for Clinical 
  Electrophysiology of Vision standards.10 As a reference, 
normal full-field electrophysiologic waveforms are included 
in Figure 1A. The vertical marks denote the stimulus flash. 
In brief, the parameters measured were: a 30 Hz flicker (in 
a light-adapted patient, cone responses are evoked by a 
stimulus flickering at 30 Hz); a photopic single flash (in a 
light-adapted patient, a bright white flash stimulus evokes 
primarily a cone-mediated response, ie, the so-called 
“cone-ERG”); scotopic oscillatory potentials (OP; in a dark-
adapted patient, a variable response in the positive deflec-
tion, felt to arise from amacrine cells, and these responses 
are diminished in eyes with ischemia); and scotopic single 
flash (in the dark-adapted eye is maximal response, a bright 
single white flash stimulus and in a dark-adapted eye, a 
rod-isolated response is obtained that occurs after a dark-
adapted patient receives dim white and/or a blue flash that 
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Figure 1 Representative normal waveforms full-field and multifocal electroretinograms (mfERG) are presented. A) The normal full-field electroretinogram (ERG): The 
vertical marks denote the stimulus flash. In brief, the following parameters were measured. 30 Hz flicker: In a light-adapted patient, cone responses are evoked by a stimulus 
flickering at 30 Hz. Photopic single flash: In a light-adapted patient, a bright white flash stimulus evokes primarily a cone-mediated response, the so-called “cone-ERG”. 
Scotopic oscillatory potentials (OPs): In a dark-adapted patient, a variable response in the positive deflection felt to arise from amacrine cells. These responses are diminished 
in eyes with ischemia. The scotopic single flash: In the dark-adapted eye, is maximal response, a bright single white flash stimulus. In a dark-adapted eye, a rod-isolated 
response is obtained that occurs after a dark-adapted patient received dim white and or blue flash that is below cone threshold. In so doing, the resulting waveform is almost 
exclusively a b-wave. B) The normal mfERG: The typical waveform of the primary mfERG response is a biphasic wave with an initial negative deflection followed by a positive 
peak. There may be a second negative deflection after the peak. The preferred designation is to label these three peaks N1, P1, and N2, respectively. There similarity in this 
waveform with the conventional ERG. Amplitude is measured in nanovolts and time in milliseconds. The data reporting consists of a trace array, ring averages (a concentric 
ring of averages), and topographic representation of amplitudes and P1 latencies (implicit times).Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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is below the cone threshold, and in so doing, the resulting 
waveform is almost exclusively a b-wave).
Multifocal ERG (mfERG) was performed in two patients 
using the Veris system (EDI, San Mateo, CA) with a protocol 
that used 103 hexagons, Burian-Allen bipolar electrodes, dilated 
pupils, refraction adjusted to the 40 cm test distance, band-pass 
of 10–300 Hz, and a testing time of eight minutes divided into 
60-second segments.11 In brief, mfERG is a technique for assess-
ing the local electrical response from numerous regions of the 
posterior retina. The typical waveform of the primary mfERG 
response is a biphasic wave with an initial negative deflection 
followed by a positive peak (Figure 1B). There may be a second 
negative deflection after the peak. The preferred designation is 
to label these three peaks N1, P1, and N2, respectively. There 
may be similarity in this waveform with the conventional ERG. 
Amplitude is measured in nanovolts and time in milliseconds. 
The data reporting consists of a trace array, ring averages (a 
concentric ring of averages) and topographic representation of 
amplitudes and P1 latencies (implicit times).
Results
Four patients were identified. Underlying disease, transplant 
history, immunosuppressive regimen, presenting visual 
  acuity, visual acuity at final follow-up, and other patient data 
are summarized in Table 1. The mean age of the patients 
was 43 (range 31–71) years. The mean follow-up time 
was 5.9 (range 2  –13) years. The mean time to presentation 
was 14 (range 6–24) months post-transplantation, and the 
mean visual acuity of all affected eyes at presentation was 
20/50 (range 20/30–20/80). Three patients developed pro-
gressive vision loss to hand motions ranging from 20/60. One 
patient remained stable clinically and retained 20/40 visual 
acuity over the 2.5 year follow-up period.
Case 1
A 71-year-old male with a history of end-stage heart fail-
ure who underwent cardiac transplantation 10 years prior 
to presentation was seen for gradual, bilateral vision loss 
and nyctalopia starting 24 months after transplantation. His 
immunosuppressive regimen consisted of cyclosporine 150 mg 
twice daily and prednisone 7.5 mg once daily. Best corrected 
vision was 20/80 in the right eye and 20/40 in the left. Dilated 
examination revealed areas of mottled pigmentation atrophy 
and hyperpigmentation throughout the posterior pole. No 
retinal vascular abnormalities were present, and the peripheral 
retina was unremarkable. Fluorescein angiography revealed 
mottled hypo- and hyperfluorescence with multiple areas of 
focal leakage. Areas of nonperfusion were absent (Figure 2). 
A full-field ERG revealed subnormal rod and cone responses 
with prolonged implicit times when compared with normal. 
Light-adapted cone amplitudes (30 Hz flicker, photopic single 
flash) were significantly lower in the right eye and mildly 
  subnormal in the left eye, with prolonged implicit times in both 
eyes (Figure 3). The patient’s vision declined progressively 
Table 1 Summary of four identified patients, their underlying disease, transplant history, immunosuppressive regimen, presenting visual 
acuity, visual acuity at final follow-up, and summary of electroretinogram results
Age  
(years)
Gender Transplant  
history
Immunosuppressant Snellen VA  
right left
Snellen VA last  
follow-up right left 
ERG/mfERG
71 M Cardiac  
transplant
Prednisone 7.5 mg daily  
Cyclosporin 300 mg  
twice daily
20/80  
20/40
HMCF 2ft  
(two years)
Full-field ERG  
Moderately subnormal amplitudes 
of rod and and dark-adapted cone 
responses; prolonged implicit times
66 M Bone marrow  
transplant
imuran 150 mg daily  
Tacrolimus 1 mg  
three times daily  
Prednisone 7.5 mg daily
20/40  
20/40
20/40  
20/40  
(2.5 years)
Full-field ERG  
Moderately decreased rod and cone 
amplitudes; prolonged implicit times; 
severely subnormal responses of rods 
and cones
45 M Bone marrow  
transplant
Azathioprine 150 mg daily  
Tacrolimus 1 mg  
three times daily  
Prednisone 7.5 mg daily 
20/50  
20/40
CF 4ft  
20/400  
(3.3 years)
Full-field ERG  
Normal rod, severely subnormal cone 
amplitudes; prolonged implicit times  
mferG severely subnormal cone 
amplitudes
48 M renal  
transplant
Prednisone 7.5 mg daily  
Cyclosporin 300 mg  
twice daily
20/30  
20/80
20/60  
20/200  
(14 years)
Full-field ERG  
Normal rod amplitudes; moderately 
subnormal cone amplitudes  
mferG severely subnormal cone 
amplitudes
Abbreviations: mferG, multifocal electroretinogram; VA, visual acuity; erG, electroretinogram.Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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Figure 2 A 71-year old Caucasian male with a history of cardiac transplantation. A) Color fundus photograph shows retinal pigment epithelial (RPE) changes. B–E) Fluorescein 
angiogram reveals areas of mottled hypo- and hyperfluorescence with multiple areas of leakage in later frames. F) Time domain optical coherence tomography line scans 
reveal shallow subfoveal detachments.
over a two-year period, and was hand motions and counting 
fingers at two feet in the right and left eye, respectively.
Case 2
A 66-year-old Caucasian male with a history of multiple myeloma 
who had undergone an autologous bone marrow transplant three 
years prior to presentation was seen for slowly progressive, bilateral 
vision loss that began six months   following transplantation. His 
immunosuppressive regimen consisted of prednisone 7.5 mg daily 
and cyclosporine 150 mg twice daily. Visual acuity was 20/40 in 
both eyes. Dilated ophthalmoscopy revealed symmetric, mottled 
pigmentation of the posterior poles. There were shallow serous 
foveal detachments bilaterally. A full-field ERG demonstrated 
moderately decreased amplitudes under photopic and scotopic con-
ditions. Implicit times were prolonged. A multifocal ERG showed 
moderate central cone dysfunction. Two years after his initial 
presentation, his vision and clinical appearance were unchanged.
Case 3
A 45-year-old male with a history of multiple myeloma 
with kappa light chain deposition disease and a prior bone 
marrow transplant presented for vision loss that began 
12 months after transplantation. He previously underwent 
four cycles of vincristine, adriamycin, and dexamethasone, 
and had a complete response. Subsequently, he was main-
tained on prednisone 7.5 mg daily and azathioprine 150 
mg twice daily. His presenting visual acuity was 20/50 in 
the right eye and 20/40 in the left. Dilated fundus examina-
tion showed several small, approximately 150 µm white 
flecks in the outer retina of the posterior pole in both eyes. 
The retinal vasculature and the periphery were unremark-
able. A full-field ERG revealed normal rod function and 
severely subnormal cone amplitudes. The implicit times 
were prolonged. Multifocal ERG revealed marked central 
cone dysfunction. Over three years, he displayed progres-
sive pigmentary atrophy in both eyes (Figure 4). His vision 
worsened to counting fingers in the right eye and 20/400 
in the left.
Case 4
A 48-year-old Caucasian male with membranoproliferative 
glomerulonephritis had undergone renal transplantation Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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15 years prior to presentation. He developed graft rejec-
tion, and subsequently received a second transplant seven 
years prior to presentation. He did well following the 
second graft, and his immunosuppression consisted of oral 
cyclosporine 300 mg twice daily and prednisone 7.5 mg 
daily. Fourteen months following the second transplant, 
he began to note blurred vision bilaterally. Upon presen-
tation, visual acuity was 20/30 in the right eye and 20/80 
in the left. Dilated ophthalmoscopy was significant for a 
serous detachment of the left macula. The steroids were 
discontinued and his serous detachment improved over a 
three-month period. However, his visual acuity remained 
unchanged. Full-field ERG testing revealed moderate cone 
dysfunction but normal rod amplitudes. Implicit times were 
normal. The multifocal ERG demonstrated severe central 
cone dysfunction in both eyes. Over a 14-year period, he 
developed progressive pigmentary atrophy in both eyes and 
his corrected vision worsened to 20/60 in the right eye and 
20/200 in the left.
Discussion
Patients with transplantation-associated chorioretinopathy 
may present with serous retinal detachments, RPE changes, 
and retinal microvascular abnormalities. These findings have 
been described in patients who have undergone renal, heart, 
combined heart/lung, and bone marrow transplants.1–5,8
In our series of four patients, the mean presenting visual 
acuity was 20/50. Three patients developed progressive 
vision loss ranging from 20/60 to hand motions. One patient 
remained stable clinically and retained 20/40 visual acuity 
over the follow-up period of 2.5 years.
Clinical heterogeneity was observed, with variable 
degrees of RPE disturbance and photoreceptor dysfunction 
between patients. In all patients, the degree of RPE distur-
bance and photoreceptor dysfunction appeared symmetric 
between fellow eyes. Dilated funduscopic examination find-
ings at presentation ranged from minimal RPE changes in two 
patients to severe pigmentary atrophy in the other two. Six 
of eight (75%) eyes developed serous retinal detachments at 
some point during follow-up. Retinal vascular changes were 
not observed in this series.
We assessed the degree of photoreceptor dysfunction 
experienced by patients using ERG testing. ERG in all 
four patients revealed subnormal cone a-wave amplitudes 
ranging from moderate to severe in all patients. Two of 
four patients demonstrated moderate rod dysfunction. The 
implicit times were prolonged in three of four patients. In 
two patients, the clinical changes and visual acuity were 
consistent with the severity of the observed ERG abnor-
malities (cases 1 and 2). Interestingly, the other two patients 
(cases 3 and 4) presenting with marked cone dysfunction 
by ERG and exhibited only mild pigmentary changes. Over 
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No Background
Photopic single flash
Scotopic single flash
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white +0.6 log cd-s/m2
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Figure 3 Full-field electroretinogram (ERG) of the patient depicted in Figure 1. A control tracing is included for comparison. There are decreased photopic and scotopic 
amplitudes bilaterally. The implicit times are also prolonged.Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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the follow-up period, however, these two patients developed 
severe bilateral pigmentary atrophy and progressive visual 
loss.
Although the availability of retinal electrophysiologic 
testing may be variable, in certain practice environments, 
organ transplant patients often obtain a portion or all of their 
care at academic institutions where ERG testing or referral 
to an appropriate center is generally possible. In instances of 
decreased vision in these patients, in the absence of discern-
ible findings of retinal ophthalmoscopic pathology, obtaining 
electrophysiologic testing may help localize the cause of the 
patient’s vision loss.
The presence of subnormal cone dysfunction prior to 
the development of clinically apparent pigmentary changes 
suggests a primary retinal abnormality rather than an epi-
theliopathy with secondary retinal dysfunction. The ERG 
findings are not able to define the etiology of transplant 
chorioretinopathy precisely because other causes, such as 
ischemia and chronic serous detachment, could result in a 
similar ERG pattern.7,12–18 Nevertheless, ERG findings may 
be of clinical utility in counseling patients because they may 
serve as an early indicator of a poor clinical course. In the 
future, with better understanding of the pathophysiology 
of this condition, detection of ERG dysfunction may serve 
as an opportunity for modulatory intervention to mitigate 
imminent vision loss.
In summary, transplant chorioretinopathy is a rare 
and potentially debilitating complication that may follow 
solid organ or bone marrow transplantation. In this series 
of patients, ERG findings revealed severe cone dysfunc-
tion with a variable amount of rod dysfunction. These 
  abnormalities may precede the onset of clinically evident 
changes, as seen in two of four patients in our series. They 
may also provide some insight into the early changes of 
this retinal   degenerative process and may be a harbinger of 
future visual loss. Because the spectrum of transplant chori-
oretinopathy may vary from mild RPE changes to clinically 
evident serous retinal detachment, ERG testing should be 
considered in patients with suspicious examination findings. 
Further   studies are needed on the pathogenesis and manage-
ment of this unusual entity.
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Figure 4 A 45-year-old Caucasian male with a history of bone marrow transplantation following treatment for multiple myeloma. A) On initial presentation, visual acuity 
was 20/40. Fundus examination was significant for small drusen-like deposits in the macula. B) Multifocal electroretinogram (ERG) performed at presentation was notable 
for severely decreased central cone amplitudes. C) The trace array reveals central tracings with reduced amplitude and increased implicit times. The topographic amplitude 
map discloses depressed central amplitude. The ring averages reveal abnormal latencies in the central group of tracings (1 and 2) compared to the concentric outer groups 
(5 and 6). The topographic P1 latency map disclosed increased implicit times centrally (red and yellow) compared with outer areas. Three years later, the visual acuity has 
decreased to 20/400, and there is diffuse pigmentary atrophy.Clinical Ophthalmology
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